Advertisement

 

 

CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses.

CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses.
Author Information (click to view)

Borca MV, Holinka LG, Berggren KA, Gladue DP,


Borca MV, Holinka LG, Berggren KA, Gladue DP, (click to view)

Borca MV, Holinka LG, Berggren KA, Gladue DP,

Advertisement

Scientific reports 2018 02 168(1) 3154 doi 10.1038/s41598-018-21575-8
Abstract

African swine fever virus (ASFV) causes a highly contagious disease called African swine fever. This disease is often lethal for domestic pigs, causing extensive losses for the swine industry. ASFV is a large and complex double stranded DNA virus. Currently there is no commercially available treatment or vaccine to prevent this devastating disease. Development of recombinant ASFV for producing live-attenuated vaccines or studying the involvement of specific genes in virus virulence has relied on the relatively rare event of homologous recombination in primary swine macrophages, causing difficulty to purify the recombinant virus from the wild-type parental ASFV. Here we present the use of the CRISPR-Cas9 gene editing system as a more robust and efficient system to produce recombinant ASFVs. Using CRISPR-Cas9 a recombinant virus was efficiently developed by deleting the non-essential gene 8-DR from the genome of the highly virulent field strain Georgia07 using swine macrophages as cell substrate.

Submit a Comment

Your email address will not be published. Required fields are marked *

four × four =

[ HIDE/SHOW ]